Five notes:
1. Researchers analyzed 1,001 venture capital investments in the PitchBook database across 227 spine surgery companies.
2. Investments were categorized into five groups: surgical devices, noninvasive devices, biotechnology, surgical software, and clinical services.
3. A total $5.3 billion was invested in spine surgery, and nonsurgical devices saw the lion’s share of 42.6%.
4. Surgical device investments made up 26.3% of that $5.3 billion, and biotechnology saw 22.2% of the share.
5. Annual investments increased by 1,782%, but there was a decline in 2023. That decline was “likely due to macroeconomic factors,” the study said.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
